Gyre Therapeutics Inc (GYRE)

R&D Expense Growth

184.00%

Quarterly · Period ending:

GYRE logo

GYRE R&D Expense Growth

Latest reported184.00%
GYRE Quarterly R&D Growth (QoQ) (0.00% → 184.00%)
High-resolution chart · PNG

GYRE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
184.0012%
39.9377%
103.7664%
-71.704%
169.8223%
-16.6218%
33.7658%
-17.2876%
53.758%
-52.2329%
51.8112%
-15.667%
35.408%
-57.6241%
-1.032%
248.2813%
-81.1887%
-40.564%
-20.3878%
32.0842%
-9.8101%
17.2421%
18.4668%
-5.0907%
-2.699%
22.8945%
8.7237%
-10.6561%
-7.6162%
45.9765%
47.7848%
43.353%
3.1291%
5.8972%
-6.4126%
11.8789%
65.017%
-33.7725%
-8.3628%
23.4012%
20.385%
29.4451%
18.8425%
306.0109%
-82.2674%
117.3796%
-2.5827%
-31.199%
-197.1806%
-15.5663%
4.2863%
9.0755%
13.6298%
-32.577%
91.7936%
-48.5774%
-29.7118%
-31.7158%
2.4564%
26.054%
-14.1685%
4.5758%
29.7709%
22.7092%
33.1385%
5.964%
4%
-12.888%
16.3665%
-10.9684%
-0.4878%
1.8958%
15.8128%
-8.3899%
5.0524%
3.9342%
46.6694%
-13.2323%
34.6856%
15.2629%
-3.4694%
-15.6429%
-9.3582%
-14.5648%
43.0913%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.